|
LOC285359 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32609997929956E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53610000275251E-08 |
| Normal-vs-Stage2 |
4.07079999709126E-08 |
| Normal-vs-Stage3 |
4.52610005030607E-09 |
| Normal-vs-Stage4 |
8.223200E-03 |
| Stage1-vs-Stage2 |
5.979700E-02 |
| Stage1-vs-Stage3 |
8.177600E-02 |
| Stage1-vs-Stage4 |
5.711000E-01 |
| Stage2-vs-Stage3 |
6.076200E-01 |
| Stage2-vs-Stage4 |
1.054010E-01 |
| Stage3-vs-Stage4 |
1.761850E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28150001721394E-09 |
| Normal-vs-AfricanAmerican |
4.460800E-03 |
| Normal-vs-Asian |
3.073700E-02 |
| Caucasian-vs-AfricanAmerican |
5.186800E-01 |
| Caucasian-vs-Asian |
1.785510E-04 |
| AfricanAmerican-vs-Asian |
1.854180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.343390E-03 |
| Normal-vs-Female |
3.21098703182088E-12 |
| Male-vs-Female |
1.217530E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.6266000010049E-08 |
| Normal-vs-Age(41-60Yrs) |
6.12629946772358E-11 |
| Normal-vs-Age(61-80Yrs) |
8.00210000000412E-05 |
| Normal-vs-Age(81-100Yrs) |
6.13659999999516E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.480970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.519200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.359200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.273200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.907400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.832420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.378400E-03 |
| Classical-VS-Follicular |
3.711400E-01 |
| Classical-VS-Other |
5.617800E-01 |
| Classical-VS-Normal |
3.20520000540725E-08 |
| Tall-VS-Follicular |
3.321500E-03 |
| Tall-VS-Other |
2.721700E-02 |
| Tall-VS-Normal |
1.2297000084871E-09 |
| Follicular-VS-Other |
7.881600E-01 |
| Follicular-VS-Normal |
8.32750000000493E-05 |
| Other-VS-Normal |
1.068390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.91749999609326E-08 |
| Normal-vs-N1 |
2.724000E-02 |
| N0-vs-N1 |
1.818360E-01 |
|
|
